Who We Are
Universal Stabilization Technologies, Inc. ("UST") is a San Diego-based biopharmaceutical R&D company and provider of leading stabilization and delivery enabling technologies with higher yields and at higher storage temperatures than currently possible. UST’s proprietary process allows the stabilization and delivery of fragile vaccines and biologics during long-term storage, transport, and distribution. UST also develops novel methods for mucosal and transdermal delivery of biological materials.
What We Do
UST collaborates with industry, academia, and government to help them develop and deliver thermostable vaccines and biological products.
UST offers a patented drying process to address the significant stability challenges associated with refrigerated storage and freeze-drying biologicals.
Our ability to overcome these challenges and deliver superior results make us a unique and compelling formulation and product development partner.
Victor Bronshtein, Ph.D.
President & CSO
Dr. Bronshtein is the founder, Chief Scientific Officer, and President of Universal Stabilization Technologies, Inc. since 2002. He is an inventor, entrepreneur and biophysicist having devoted his professional career to investigating and protecting biomacromolecules, membranes, viruses, bacteria, mammalian cells and multicellular specimens from damage during cryopreservation and preservation in the dry state. Dr. Bronshtein holds over 100 patents and patent applications worldwide, and has pioneered several preservation technologies including Preservation by Vaporization (PBV), currently the only industrial scale foam drying technology for biopharmaceuticals. Dr. Bronshtein holds a Post Doc from Cornell University, and an MS and PhD from Moscow State University.
Contact Email: firstname.lastname@example.org
Head of Business Development
Alex joined UST in 2014 and leads business development, partnerships, and in-and-out licensing transactions. Alex has been instrumental in developing collaborations with industry, government, and academic institutions. He is responsible for executing UST’s vision and strategy and leads licensing transactions and partnerships. Prior to UST, Alex held business and corporate development positions where he was responsible for strategy and M&A. Alex is a graduate of San Diego State University with a degree in business finance and resides in San Diego with his wife and three children.
Contact Email: email@example.com
Vivian Lauderdale, MS, MBA, RAC
Vice President, Regulatory Affairs & QA/QC
Vivian brings over 25 years of experience from the biotechnology industry with expertise in regulatory affairs, cGMP quality systems, and biomedical business management. She has strong grant writing expertise and has successfully obtained awards from the SBIR, NIH, DoD, and NSF. She also holds a Regulatory Affairs Certification (RAC) from the US Regulatory Affairs Professional Society (RAPS). Vivian holds an MS from George Washington University Medical School Division and an Executive MBA from UCLA.
Contact Email: firstname.lastname@example.org